Literature DB >> 10728166

Hyperphagia and self-mutilation in Prader-Willi syndrome: psychopharmacological issues.

J A Yaryura-Tobias1, M S Grunes, M E Bayles, F Neziroglu.   

Abstract

This study focused in the treatment of two major Prader-Willi symptoms: hyperphagia and self-injurious behavior (SIB). Four patients participated in a four-year study with monthly follow-ups. Patients lived in a behaviorally structured environment, and were treated with selective serotonin reuptake blockers and phenothiazines. Psychopharmacological intervention improved SIB symptoms, but was ineffective to control appetite satiation.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10728166     DOI： 10.1007/bf03340005

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN： 1124-4909            Impact factor:   4.652


  17 in total

1.  Second Annual Prader-Willi Syndrome Scientific Conference. Houston, June 17, 1987. Proceedings and abstracts.

Authors: 
Journal:  Am J Med Genet       Date:  1987-12

2.  Tentative classification of neuropsychiatric disturbances in Prader-Willi syndrome.

Authors:  G Bartolucci; J Younger
Journal:  J Intellect Disabil Res       Date:  1994-12

3.  Gilles de la Tourette syndrome. Interactions with other neuropsychiatric disorders.

Authors:  J A Yaryura-Tobias
Journal:  Acta Psychiatr Scand       Date:  1979-01       Impact factor: 6.392

4.  Psychological profile and behavioural characteristics in 12 patients with Prader-Willi syndrome.

Authors:  M Borghgraef; J P Fryns; H Van Den Berghe
Journal:  Genet Couns       Date:  1990

5.  Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.

Authors:  J W Bodfish; J T Madison
Journal:  Am J Ment Retard       Date:  1993-11

Review 6.  Pharmacological treatment of self-injurious behavior in mentally retarded persons.

Authors:  N N Singh; C J Millichamp
Journal:  J Autism Dev Disord       Date:  1985-09

7.  Behavioral monitoring of pharmacological interventions for self-injury.

Authors:  N N Singh; A S Winton
Journal:  Appl Res Ment Retard       Date:  1984

8.  Duplication of proximal 15q as a cause of Prader-Willi syndrome.

Authors:  A L Pettigrew; S M Gollin; F Greenberg; V M Riccardi; D H Ledbetter
Journal:  Am J Med Genet       Date:  1987-12

9.  Naltrexone and fluoxetine in Prader-Willi syndrome.

Authors:  E Benjamin; T Buot-Smith
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1993-07       Impact factor: 8.829

10.  Psychopharmacogenetic aspects of Prader-Willi syndrome.

Authors:  J B Tu; C Hartridge; J Izawa
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-11       Impact factor: 8.829
View more
  1 in total

1.  Topiramate in the treatment of Prader-Willi syndrome: A case report.

Authors:  Nicole East; Megan Maroney
Journal:  Ment Health Clin       Date:  2018-03-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.